[go: up one dir, main page]

NO20091117L - 3,4-dihydrobenzo[1,2,3]tiadiazin-1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende nevnte derivater og deres anvendelse - Google Patents

3,4-dihydrobenzo[1,2,3]tiadiazin-1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende nevnte derivater og deres anvendelse

Info

Publication number
NO20091117L
NO20091117L NO20091117A NO20091117A NO20091117L NO 20091117 L NO20091117 L NO 20091117L NO 20091117 A NO20091117 A NO 20091117A NO 20091117 A NO20091117 A NO 20091117A NO 20091117 L NO20091117 L NO 20091117L
Authority
NO
Norway
Prior art keywords
derivatives
thiadiazine
dihydrobenzo
preparation
drugs containing
Prior art date
Application number
NO20091117A
Other languages
English (en)
Inventor
Jozsef Barkoczy
Laszlo Gabor Harsing
Tibor Mezei
Gyorgy Levay
Gyula Simig
Marta Porcs-Makkay
Csilla Leveleki
Istvan Gacsalyi
Gyula Lukacs
Gabor Kapus
Miklos Vegh
Szabolcs Kertesz
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Publication of NO20091117L publication Critical patent/NO20091117L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives nye 3,4-dihydrobenzo[l,2,3]tiadiazin-l,l-dioksidderivater med formel (I). Det beskrives videre medikamenter inneholdene disse nye forbindelser samt fremgangsmåter for fremstilling derav og anvendelse av disse derivatene innen medisin. Forbindelsene ifølge oppfinnelsen er egnet for terapi eller prevensjon av forstyrrelser i sentralnervesystemet.
NO20091117A 2006-08-16 2009-03-13 3,4-dihydrobenzo[1,2,3]tiadiazin-1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende nevnte derivater og deres anvendelse NO20091117L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0600651A HU230749B1 (hu) 2006-08-16 2006-08-16 3,4-Dihidrobenzo[1,2,3]tiadiazin-1,1-dioxid-származékok, eljárás előállításukra, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
PCT/HU2007/000072 WO2008020256A2 (en) 2006-08-16 2007-08-13 3,4-dihydrobenzo[1,2,3]thiadiazine-1,1-dioxide derivatives, process for preparation thereof, medicaments containing said derivatives and their use

Publications (1)

Publication Number Publication Date
NO20091117L true NO20091117L (no) 2009-05-06

Family

ID=89986972

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091117A NO20091117L (no) 2006-08-16 2009-03-13 3,4-dihydrobenzo[1,2,3]tiadiazin-1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende nevnte derivater og deres anvendelse

Country Status (11)

Country Link
US (1) US20100190778A1 (no)
EP (1) EP2064197A2 (no)
KR (1) KR20090040387A (no)
CN (1) CN101547912A (no)
AU (1) AU2007285501A1 (no)
CA (1) CA2660890A1 (no)
EA (1) EA200900312A1 (no)
HU (1) HU230749B1 (no)
IL (1) IL197068A0 (no)
NO (1) NO20091117L (no)
WO (1) WO2008020256A2 (no)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3407198A (en) * 1966-08-10 1968-10-22 Upjohn Co 2h-1, 2, 3-benzothiadiazine-1, 1-dioxides

Also Published As

Publication number Publication date
HU0600651D0 (en) 2006-10-28
CN101547912A (zh) 2009-09-30
US20100190778A1 (en) 2010-07-29
KR20090040387A (ko) 2009-04-23
HUP0600651A2 (en) 2008-03-28
HU230749B1 (hu) 2018-03-28
EP2064197A2 (en) 2009-06-03
HUP0600651A3 (en) 2008-05-28
AU2007285501A1 (en) 2008-02-21
EA200900312A1 (ru) 2009-06-30
WO2008020256A3 (en) 2008-04-10
CA2660890A1 (en) 2008-02-21
IL197068A0 (en) 2009-11-18
WO2008020256A2 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
TW200621762A (en) Novel compounds
NO20091893L (no) Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
NO20055219L (no) Nye forbindelser
BR112012010124A2 (pt) composto, uso de um animal composto, derivado de cromenona, e, método para o tratamento ou prevenção de um animal de sangue quente tendo tumores que são sensíveis á inibição das enzimas de pi 3-cinase
NO20062335L (no) Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
NO20093060L (no) Spirosykliske sykloheksanderivater
ATE365742T1 (de) 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren
NO20082065L (no) Nye imidazo[4,5-b]pyridinderivater som inhibitorer av glykogensyntasekinase 3 for anvendelse ved behandling av demens og neurodegenerative forstyrrelser
DE602005009745D1 (de) Glucopyranosyl-substituierte benzen-derivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
NO20071703L (no) Kinazolinderivater
NO20061746L (no) Kinazolinderivater som antiproliferative midler
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
MY144132A (en) Polymorph forms of (2s)-(4e)-n-methyl-5-[3-(5-isoproproxypyridin)yl]-4-penten-2-amine
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
MA31567B1 (fr) Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
NO20080033L (no) Kinolinderivater som NK3-antagonister
NO20083790L (no) Nye terapeutiske kombinasjoner for behandling eller forebygging av psykotiske lidelser
NO330888B1 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application